Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values.
<h4>Background</h4>Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0253843 |
| _version_ | 1798032113359912960 |
|---|---|
| author | Jessica E Rothman David Eidelberg Samantha L Rothman Theodore R Holford Douglas L Rothman |
| author_facet | Jessica E Rothman David Eidelberg Samantha L Rothman Theodore R Holford Douglas L Rothman |
| author_sort | Jessica E Rothman |
| collection | DOAJ |
| description | <h4>Background</h4>Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR and CFR required large adjustments for missed cases. We present an alternate approach, based on results from the countries at the time that had a high test to positive case ratio to estimate symptomatic CFR.<h4>Methods</h4>We calculated age specific (0-69, 70-79, 80+ years old) time corrected crude symptomatic CFR values from 7 countries using two independent time to fatality correction methods. Data was obtained through May 7, 2020. We applied linear regression to determine whether the mean of these coefficients had converged to the true symptomatic CFR values. We then tested these coefficients against values derived in later studies as well as a large random serological study in NYC at that time.<h4>Results</h4>The age dependent symptomatic CFR values accurately predicted the percentage of the population infected as reported by two random testing studies in NYC. They also were in good agreement with later studies that estimated age specific IFR and CFR values from serological studies and more extensive data sets available later in the pandemic.<h4>Conclusions</h4>We found that for regions with extensive testing it is possible to get early accurate symptomatic CFR coefficients. These values, in combination with an estimate of the age dependence of infection, allows symptomatic CFR values and percentage of the population that is infected to be determined in similar regions with limited testing. |
| first_indexed | 2024-04-11T20:07:34Z |
| format | Article |
| id | doaj.art-e7c3fa5b238d48a8ac8f37299d382456 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-11T20:07:34Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e7c3fa5b238d48a8ac8f37299d3824562022-12-22T04:05:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01168e025384310.1371/journal.pone.0253843Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values.Jessica E RothmanDavid EidelbergSamantha L RothmanTheodore R HolfordDouglas L Rothman<h4>Background</h4>Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR and CFR required large adjustments for missed cases. We present an alternate approach, based on results from the countries at the time that had a high test to positive case ratio to estimate symptomatic CFR.<h4>Methods</h4>We calculated age specific (0-69, 70-79, 80+ years old) time corrected crude symptomatic CFR values from 7 countries using two independent time to fatality correction methods. Data was obtained through May 7, 2020. We applied linear regression to determine whether the mean of these coefficients had converged to the true symptomatic CFR values. We then tested these coefficients against values derived in later studies as well as a large random serological study in NYC at that time.<h4>Results</h4>The age dependent symptomatic CFR values accurately predicted the percentage of the population infected as reported by two random testing studies in NYC. They also were in good agreement with later studies that estimated age specific IFR and CFR values from serological studies and more extensive data sets available later in the pandemic.<h4>Conclusions</h4>We found that for regions with extensive testing it is possible to get early accurate symptomatic CFR coefficients. These values, in combination with an estimate of the age dependence of infection, allows symptomatic CFR values and percentage of the population that is infected to be determined in similar regions with limited testing.https://doi.org/10.1371/journal.pone.0253843 |
| spellingShingle | Jessica E Rothman David Eidelberg Samantha L Rothman Theodore R Holford Douglas L Rothman Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. PLoS ONE |
| title | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. |
| title_full | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. |
| title_fullStr | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. |
| title_full_unstemmed | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. |
| title_short | Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values. |
| title_sort | analysis of the time course of covid 19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic cfr values |
| url | https://doi.org/10.1371/journal.pone.0253843 |
| work_keys_str_mv | AT jessicaerothman analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues AT davideidelberg analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues AT samanthalrothman analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues AT theodorerholford analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues AT douglaslrothman analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues |